Page last updated: 2024-10-25

cyproheptadine and Auricular Cancer

cyproheptadine has been researched along with Auricular Cancer in 1 studies

Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bates, GJ1
Luscombe, FE1

Other Studies

1 other study available for cyproheptadine and Auricular Cancer

ArticleYear
Carcinoid metastasis in the middle ear: anaesthetic and surgical management.
    Journal of the Royal Society of Medicine, 1989, Volume: 82, Issue:3

    Topics: Carcinoid Tumor; Cyproheptadine; Ear Neoplasms; Ear, Middle; Fenclonine; Humans; Ileal Neoplasms; Ke

1989